PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Clinical evidence
Oral administration of ethanolic flower extract in rats significantly increased granulation tissue weight, tensile strength, hydroxyproline, and glycosaminoglycan content, while reducing wound area [PMID:16236462].
Root extracts showed low micromolar in vitro antiplasmodial activity against chloroquine-resistant (W2) and chloroquine-sensitive (D6) strains [PMID:21979929].
Ethanol extracts of P. lanceolata roots were found to be effective against S. aureus in vitro, but not against E. coli [PMID:36324667].
An iridoids-rich fraction of P. lanceolata leaves was investigated for a possible protective role against chromosomal damage and sperm defects induced by 5-Fluorouracil in male mice [PMID:32247555].
Evidence summary
PubMed sources
- 1.PMID: 17824664 (2007) — Iridoids from Pentas lanceolata. · Journal of natural products
- 2.PMID: 21979929 (2012) — Antiplasmodial quinones from Pentas longiflora and Pentas lanceolata. · Planta medica
- 3.PMID: 30046473 (2018) — Secondary metabolites and biological activity of Pentas species: A minireview. · Journal of advanced research
- 4.PMID: 38963536 (2024) — Chemical composition and studying the possible neuroprotective effect of iridoids-rich fraction from Pentas lanceolata leaves using rotenone model of Parkinson's disease in mice. · Inflammopharmacology
- 5.PMID: 36324667 (2022) — Antimicrobial Activity of Selected Ethnoveterinary Medicinal Plants of Southern Region, Ethiopia.